Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Disufenton sodium by Oblato for Pediatric Diffuse Intrinsic Pontine Glioma: Likelihood of Approval
Disufenton sodium is under clinical development by Oblato and currently in Phase I for Pediatric Diffuse Intrinsic Pontine Glioma. According...